39 related articles for article (PubMed ID: 26454387)
1. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis.
Chen Y; Garber E; Zhao Q; Ge Y; Wikler MA; Kaniga K; Saiman L
Antimicrob Agents Chemother; 2005 Jun; 49(6):2510-1. PubMed ID: 15917558
[TBL] [Abstract][Full Text] [Related]
3. Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients.
Ajao AO; Robinson G; Lee MS; Ranke TD; Venezia RA; Furuno JP; Harris AD; Johnson JK
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1425-30. PubMed ID: 21487763
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated Efficacy.
Kim A; Kutschke A; Ehmann DE; Patey SA; Crandon JL; Gorseth E; Miller AA; McLaughlin RE; Blinn CM; Chen A; Nayar AS; Dangel B; Tsai AS; Rooney MT; Murphy-Benenato KE; Eakin AE; Nicolau DP
Antimicrob Agents Chemother; 2015 Dec; 59(12):7743-52. PubMed ID: 26438502
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity and in vivo efficacy of clavulanic acid against Acinetobacter baumannii.
Beceiro A; López-Rojas R; Domínguez-Herrera J; Docobo-Pérez F; Bou G; Pachón J;
Antimicrob Agents Chemother; 2009 Oct; 53(10):4298-304. PubMed ID: 19635957
[TBL] [Abstract][Full Text] [Related]
6. BacteSign: Building a Findable, Accessible, Interoperable, and Reusable (FAIR) Database for Universal Bacterial Identification.
Childs A; Chand D; Pereira J; Santra S; Rajaraman S
Biosensors (Basel); 2024 Apr; 14(4):. PubMed ID: 38667169
[TBL] [Abstract][Full Text] [Related]
7. Draft Genome Sequence of a Pseudomonas aeruginosa Strain Able To Decompose N,N-Dimethyl Formamide.
Yan L; Yan M; Xu L; Wei L; Zhang L
Genome Announc; 2016 Feb; 4(1):. PubMed ID: 26847883
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
[TBL] [Abstract][Full Text] [Related]
9. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.
Potron A; Poirel L; Nordmann P
Int J Antimicrob Agents; 2015 Jun; 45(6):568-85. PubMed ID: 25857949
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Efficacy of Doripenem against Pseudomonas aeruginosa and Acinetobacter baumannii by E-Test.
Gilani M; Munir T; Latif M; Rehman S; Ansari M; Hafeez A; Najeeb S; Saad N; Gilani M
J Coll Physicians Surg Pak; 2015 Oct; 25(10):726-9. PubMed ID: 26454387
[TBL] [Abstract][Full Text] [Related]
11. Doripenem vs meropenem against Pseudomonas and Acinetobacter.
Goyal K; Gautam V; Ray P
Indian J Med Microbiol; 2012; 30(3):350-1. PubMed ID: 22885206
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
13. Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
Pankuch GA; Seifert H; Appelbaum PC
Diagn Microbiol Infect Dis; 2010 Jun; 67(2):191-7. PubMed ID: 20338710
[TBL] [Abstract][Full Text] [Related]
14. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
